These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29307229)

  • 1. Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetes.
    Lévy BI; Taddei S
    Curr Med Res Opin; 2018 Sep; 34(9):1557-1570. PubMed ID: 29307229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
    Patel A; ; MacMahon S; Chalmers J; Neal B; Woodward M; Billot L; Harrap S; Poulter N; Marre M; Cooper M; Glasziou P; Grobbee DE; Hamet P; Heller S; Liu LS; Mancia G; Mogensen CE; Pan CY; Rodgers A; Williams B
    Lancet; 2007 Sep; 370(9590):829-40. PubMed ID: 17765963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ADVANCE study: objectives, design and current status].
    Chalmers J
    Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADVANCE: breaking new ground in type 2 diabetes.
    Chalmers J; Perkovic V; Joshi R; Patel A
    J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the ADVANCE study for clinical practice.
    Zannad F
    J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights from ADVANCE.
    Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A
    J Hypertens Suppl; 2007 Jun; 25(1):S23-30. PubMed ID: 17579315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation.
    ADVANCE Management Committee
    Diabetologia; 2001 Sep; 44(9):1118-20. PubMed ID: 11596665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
    Chalmers J; Arima H; Woodward M; Mancia G; Poulter N; Hirakawa Y; Zoungas S; Patel A; Williams B; Harrap S
    Hypertension; 2014 Feb; 63(2):259-64. PubMed ID: 24324048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
    Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
    J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
    Ghiadoni L
    Expert Opin Pharmacother; 2010 Jul; 11(10):1647-57. PubMed ID: 20518617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perindopril for the treatment of hypertension.
    Ghiadoni L
    Expert Opin Pharmacother; 2011 Jul; 12(10):1633-42. PubMed ID: 21599567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
    Ruilope LM; Segura J
    J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
    Zoungas S; Chalmers J; Neal B; Billot L; Li Q; Hirakawa Y; Arima H; Monaghan H; Joshi R; Colagiuri S; Cooper ME; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Matthews DR; Mogensen CE; Perkovic V; Poulter N; Rodgers A; Williams B; MacMahon S; Patel A; Woodward M;
    N Engl J Med; 2014 Oct; 371(15):1392-406. PubMed ID: 25234206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prevention of the hypertension related damage in type-2 diabetes: the first step of the ADVANCE trial].
    Nagy V
    Orv Hetil; 2008 Jan; 149(1):19-22. PubMed ID: 18089478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perindopril 2mg/indapamide 0.625mg. Fixed low-dose combination.
    McClellan KJ; Markham A
    Drugs; 1999 Aug; 58(2):297-302; discussion 303-4. PubMed ID: 10473021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of the antihypertensive effect of low-dose combination therapy in mild hypertension.
    Myers MG; Leenen FH;
    Blood Press; 2006; 15(6):325-32. PubMed ID: 17472022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
    Scheen AJ; Krzesinski JM
    Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
    Waeber B; de la Sierra A; Ruilope LM
    Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.